About Us Services Careers FAQ Contact Us 0
Home Pharmaceuticals Dermatological Therapeutics Market Size, Share, Forecast Analysis 2032
Dermatological Therapeutics Market

Dermatological Therapeutics Market Size, Share & Trends Analysis Report By Drug Class (Anti-infectives, Corticosteroids, Anti-acne, Calcineurin inhibitors, Retinoids, Others), By Applications (Alopecia, Herpes, Psoriasis, Rosacea, Atopic dermatitis, Acne vulgaris, Other applications) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2024-2032

Report Code: SRPH960DR
Author : Straits Research
Buy Now
File Formats

Table Of Content

  1. Executive Summary
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends
    1. Global Dermatological Therapeutics Market Introduction
    2. By Drug Class
      1. Introduction
        1. Drug Class By Value
      2. Anti-infectives
        1. By Value
      3. Corticosteroids
        1. By Value
      4. Anti-acne
        1. By Value
      5. Calcineurin inhibitors
        1. By Value
      6. Retinoids
        1. By Value
      7. Others
        1. By Value
    3. By Applications
      1. Introduction
        1. Applications By Value
      2. Alopecia
        1. By Value
      3. Herpes
        1. By Value
      4. Psoriasis
        1. By Value
      5. Rosacea
        1. By Value
      6. Atopic dermatitis
        1. By Value
      7. Acne vulgaris
        1. By Value
      8. Other applications
        1. By Value
    1. Introduction
    2. By Drug Class
      1. Introduction
        1. Drug Class By Value
      2. Anti-infectives
        1. By Value
      3. Corticosteroids
        1. By Value
      4. Anti-acne
        1. By Value
      5. Calcineurin inhibitors
        1. By Value
      6. Retinoids
        1. By Value
      7. Others
        1. By Value
    3. By Applications
      1. Introduction
        1. Applications By Value
      2. Alopecia
        1. By Value
      3. Herpes
        1. By Value
      4. Psoriasis
        1. By Value
      5. Rosacea
        1. By Value
      6. Atopic dermatitis
        1. By Value
      7. Acne vulgaris
        1. By Value
      8. Other applications
        1. By Value
    4. U.S.
      1. By Drug Class
        1. Introduction
          1. Drug Class By Value
        2. Anti-infectives
          1. By Value
        3. Corticosteroids
          1. By Value
        4. Anti-acne
          1. By Value
        5. Calcineurin inhibitors
          1. By Value
        6. Retinoids
          1. By Value
        7. Others
          1. By Value
      2. By Applications
        1. Introduction
          1. Applications By Value
        2. Alopecia
          1. By Value
        3. Herpes
          1. By Value
        4. Psoriasis
          1. By Value
        5. Rosacea
          1. By Value
        6. Atopic dermatitis
          1. By Value
        7. Acne vulgaris
          1. By Value
        8. Other applications
          1. By Value
    5. Canada
    1. Introduction
    2. By Drug Class
      1. Introduction
        1. Drug Class By Value
      2. Anti-infectives
        1. By Value
      3. Corticosteroids
        1. By Value
      4. Anti-acne
        1. By Value
      5. Calcineurin inhibitors
        1. By Value
      6. Retinoids
        1. By Value
      7. Others
        1. By Value
    3. By Applications
      1. Introduction
        1. Applications By Value
      2. Alopecia
        1. By Value
      3. Herpes
        1. By Value
      4. Psoriasis
        1. By Value
      5. Rosacea
        1. By Value
      6. Atopic dermatitis
        1. By Value
      7. Acne vulgaris
        1. By Value
      8. Other applications
        1. By Value
    4. U.K.
      1. By Drug Class
        1. Introduction
          1. Drug Class By Value
        2. Anti-infectives
          1. By Value
        3. Corticosteroids
          1. By Value
        4. Anti-acne
          1. By Value
        5. Calcineurin inhibitors
          1. By Value
        6. Retinoids
          1. By Value
        7. Others
          1. By Value
      2. By Applications
        1. Introduction
          1. Applications By Value
        2. Alopecia
          1. By Value
        3. Herpes
          1. By Value
        4. Psoriasis
          1. By Value
        5. Rosacea
          1. By Value
        6. Atopic dermatitis
          1. By Value
        7. Acne vulgaris
          1. By Value
        8. Other applications
          1. By Value
    5. Germany
    6. France
    7. Spain
    8. Italy
    9. Russia
    10. Nordic
    11. Benelux
    12. Rest of Europe
    1. Introduction
    2. By Drug Class
      1. Introduction
        1. Drug Class By Value
      2. Anti-infectives
        1. By Value
      3. Corticosteroids
        1. By Value
      4. Anti-acne
        1. By Value
      5. Calcineurin inhibitors
        1. By Value
      6. Retinoids
        1. By Value
      7. Others
        1. By Value
    3. By Applications
      1. Introduction
        1. Applications By Value
      2. Alopecia
        1. By Value
      3. Herpes
        1. By Value
      4. Psoriasis
        1. By Value
      5. Rosacea
        1. By Value
      6. Atopic dermatitis
        1. By Value
      7. Acne vulgaris
        1. By Value
      8. Other applications
        1. By Value
    4. China
      1. By Drug Class
        1. Introduction
          1. Drug Class By Value
        2. Anti-infectives
          1. By Value
        3. Corticosteroids
          1. By Value
        4. Anti-acne
          1. By Value
        5. Calcineurin inhibitors
          1. By Value
        6. Retinoids
          1. By Value
        7. Others
          1. By Value
      2. By Applications
        1. Introduction
          1. Applications By Value
        2. Alopecia
          1. By Value
        3. Herpes
          1. By Value
        4. Psoriasis
          1. By Value
        5. Rosacea
          1. By Value
        6. Atopic dermatitis
          1. By Value
        7. Acne vulgaris
          1. By Value
        8. Other applications
          1. By Value
    5. Korea
    6. Japan
    7. India
    8. Australia
    9. Singapore
    10. Taiwan
    11. South East Asia
    12. Rest of Asia-Pacific
    1. Introduction
    2. By Drug Class
      1. Introduction
        1. Drug Class By Value
      2. Anti-infectives
        1. By Value
      3. Corticosteroids
        1. By Value
      4. Anti-acne
        1. By Value
      5. Calcineurin inhibitors
        1. By Value
      6. Retinoids
        1. By Value
      7. Others
        1. By Value
    3. By Applications
      1. Introduction
        1. Applications By Value
      2. Alopecia
        1. By Value
      3. Herpes
        1. By Value
      4. Psoriasis
        1. By Value
      5. Rosacea
        1. By Value
      6. Atopic dermatitis
        1. By Value
      7. Acne vulgaris
        1. By Value
      8. Other applications
        1. By Value
    4. UAE
      1. By Drug Class
        1. Introduction
          1. Drug Class By Value
        2. Anti-infectives
          1. By Value
        3. Corticosteroids
          1. By Value
        4. Anti-acne
          1. By Value
        5. Calcineurin inhibitors
          1. By Value
        6. Retinoids
          1. By Value
        7. Others
          1. By Value
      2. By Applications
        1. Introduction
          1. Applications By Value
        2. Alopecia
          1. By Value
        3. Herpes
          1. By Value
        4. Psoriasis
          1. By Value
        5. Rosacea
          1. By Value
        6. Atopic dermatitis
          1. By Value
        7. Acne vulgaris
          1. By Value
        8. Other applications
          1. By Value
    5. Turkey
    6. Saudi Arabia
    7. South Africa
    8. Egypt
    9. Nigeria
    10. Rest of MEA
    1. Introduction
    2. By Drug Class
      1. Introduction
        1. Drug Class By Value
      2. Anti-infectives
        1. By Value
      3. Corticosteroids
        1. By Value
      4. Anti-acne
        1. By Value
      5. Calcineurin inhibitors
        1. By Value
      6. Retinoids
        1. By Value
      7. Others
        1. By Value
    3. By Applications
      1. Introduction
        1. Applications By Value
      2. Alopecia
        1. By Value
      3. Herpes
        1. By Value
      4. Psoriasis
        1. By Value
      5. Rosacea
        1. By Value
      6. Atopic dermatitis
        1. By Value
      7. Acne vulgaris
        1. By Value
      8. Other applications
        1. By Value
    4. Brazil
      1. By Drug Class
        1. Introduction
          1. Drug Class By Value
        2. Anti-infectives
          1. By Value
        3. Corticosteroids
          1. By Value
        4. Anti-acne
          1. By Value
        5. Calcineurin inhibitors
          1. By Value
        6. Retinoids
          1. By Value
        7. Others
          1. By Value
      2. By Applications
        1. Introduction
          1. Applications By Value
        2. Alopecia
          1. By Value
        3. Herpes
          1. By Value
        4. Psoriasis
          1. By Value
        5. Rosacea
          1. By Value
        6. Atopic dermatitis
          1. By Value
        7. Acne vulgaris
          1. By Value
        8. Other applications
          1. By Value
    5. Mexico
    6. Argentina
    7. Chile
    8. Colombia
    9. Rest of LATAM
    1. Dermatological Therapeutics Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. Allergen plc
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Novartis
    3. Sanofi
    4. Dermira
    5. Pfizer Inc.
    6. GlaxoSmithKline Plc.
    7. Foamix Pharmaceutical
    8. Sun Pharmaceutical
    9. Mayne Pharma
    10. Glenmark Pharmaceutical
    11. Valeant Pharmaceuticals
    12. Galderma SA
    13. AbbVie Inc.
    14. Amgen Inc.
    15.  Eli Lilly
    16. AstraZeneca
    17. Johnson and Johnson
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Related Reports

Global Report
The global cervical cancer therapeutics market size was valued at USD 5.80 billion in 2022. It is estimated to reach USD 8.59 billion by 2031, growing at a CAGR of 4.47% during the forecast period (2023–2031). The cells of the cervix, or
Buy Now
Global Report
The global dermatological drugs market size was valued at USD 17.09 billion in 2021, and it is anticipated to reach USD 37.85 billion by 2030 at a CAGR of 10.45% during the forecast period(2022-2030). The primary focus of the medical speciality known
Buy Now

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report

We are featured on :

www.straitsresearch.com
© Copyright 2025. All rights Reserved.